JPH0324198B2 - - Google Patents
Info
- Publication number
- JPH0324198B2 JPH0324198B2 JP58218895A JP21889583A JPH0324198B2 JP H0324198 B2 JPH0324198 B2 JP H0324198B2 JP 58218895 A JP58218895 A JP 58218895A JP 21889583 A JP21889583 A JP 21889583A JP H0324198 B2 JPH0324198 B2 JP H0324198B2
- Authority
- JP
- Japan
- Prior art keywords
- bilirubin
- acts
- optimal
- oxidase
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 46
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 27
- 230000000694 effects Effects 0.000 claims description 18
- 239000010949 copper Substances 0.000 claims description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 claims description 8
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 8
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000127897 Ganoderma tsunodae Species 0.000 claims description 5
- 238000002523 gelfiltration Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 4
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 2
- 102000004316 Oxidoreductases Human genes 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 30
- 108090000790 Enzymes Proteins 0.000 description 30
- 229940088598 enzyme Drugs 0.000 description 30
- 239000008363 phosphate buffer Substances 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 9
- 241000221198 Basidiomycota Species 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 239000012506 Sephacryl® Substances 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241001103808 Albifimbria verrucaria Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex⢠Substances 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000223251 Myrothecium Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
æ¬çºæã¯æ
åèããšãã¿ã±å±ïŒTrachydermaïŒ
ã®çç£ããæ°èŠããªã«ãã³ã»ãªãã·ããŒãŒããã³
ãã®è£œé æ³ã«é¢ãããã®ã§ããã
ããªã«ãã³ã¯ãã¢ã°ããã³ã®å解ã«ããè¡æ¶²äž
ã«çæããé»è²ç©è³ªã§ãããè¡æž
äžã®ããªã«ãã³
ãè¿
éãã€æ£ç¢ºã«æ€åºããããšã¯ã人éã®ç
æ°
ïŒäŸãã°é»ã ãïŒã®ç¶æ
ãå»åŠçã«èšºæããã®ã«
éåžžã«éèŠã§ãããå³ã¡é»ã ãã®æ£è
ã§ã¯è¡æž
äž
ã®ããªã«ãã³ãç°åžžã«å¢å ããã®ã§ãè¡æž
äžã®ã
ãªã«ãã³ã枬å®ããããšã«ããé»ã ãã®çšåºŠã蚺
æå¯èœã§ããããã®ããã«è¡æž
äžã®ããªã«ãã³ã
å®éããå Žåãããªã«ãã³ã»ãªãã·ããŒãŒãå©çš
ããããããã®ä»ã«æ¬é
µçŽ ã¯ããªã«ãã³ä»¥å€ã®è¢«
æ€äœãåæããå Žåã«æž¬å®å€ã®èª€å·®èŠå ãšãªãã
ãªã«ãã³ãé€å»ããã®ã«ãæçšã§ãããè¡æž
äžã®
ã°ã«ã³ãŒã¹ãããã¯ã³ã¬ã¹ãããŒã«ãªã©ã枬å®ã
ãå Žåãã°ã«ã³ãŒã¹ã»ãªãã·ããŒãŒãã³ã¬ã¹ãã
ãŒã«ã»ãªãã·ããŒãŒãªã©ãè¡æž
ã«äœçšãããçæ
ããéé
žåæ°ŽçŽ ãããŒãªãã·ããŒãŒã§æç²ããæ¯
è²æ³ãæ¥åžžæ€æ»æ³ãšããŠæãå©çšãããŠãããç¹
ã«ïŒâã¢ããã¢ã³ãããªã³âããšããŒã«ãçšãã
çºè²æ³ã¯ç°¡åãã€è¿
éã®äžãè©Šè¬ã®å®å®æ§ã®é¢ã
ããé
µçŽ æ³ã®äž»æµãšãªã€ãŠããŠããããã®æ¯è²æ³
ã¯çæããèµ€è²ããã³è²çŽ ã500nïœã§æž¬å®ãã
ã®ã§ããããè¡æž
äžã®ããªã«ãã³ã®ååšã¯è² ã®èª€
å·®ãäžãããããã§ããããããããªã«ãã³ã»ãª
ãã·ããŒãŒãè¡æž
ã«äœçšãããããªã«ãã³ãé€å»
ããåŸãè¡æž
ã«ã°ã«ã³ãŒã¹ã»ãªãã·ããŒãŒããã
ã¯ã³ã¬ã¹ãããŒã«ã»ãªãã·ããŒãŒãäœçšããã
ã°ãè¡æž
äžã®æ£ç¢ºãªã°ã«ã³ãŒã¹å€ãããã¯ã³ã¬ã¹
ãããŒã«å€ãåŸãããšãã§ããã
ããªã«ãã³ã»ãªãã·ããŒãŒã«ã€ããŠã¯ã¢ãŒã«ã»
ãããã«ã»ã³ïŒR.BrodersenïŒããã³ããŒã»ãã«
ãã«ã¹ïŒP.BortelsïŒã«ãã€ãŠæåã«å ±åãããŠ
ããããŠã¢ããã¢ã³ã»ãžã€ãŒãã«ã»ãªãã»ãã€ãª
ã±ãã¹ããªãŒïŒEurop.J.BiochemïŒç¬¬10巻第468
é ïŒ1969幎ïŒãã圌ãã¯ããªã«ãã³ãã¢ã«ã¢ããã®
è³ããåé¢ããäžæº¶æ§ã®ããªã«ãã³ã»ãªãã·ããŒ
ãŒã«ããããªãã«ãžã³ãžé
žåããããšå ±åããŠã
ãããŸãããã®ãã®äžçš®ã¢ã¬ãªã«ã¹ã»ãã¹ããŒã©
ã¹ïŒAgaricusbisporusïŒã®èèžæ±ãããªã«ãã³
ãé
žåãéé
žåæ°ŽçŽ ãçæããé
žçŽ 掻æ§ãæãã
ãšã®å ±åãããïŒç¹å
¬æ58â11194å·ïŒãããã«ã
æè¿ãããã»ã·ãŠã å±ã«å±ããããã»ã·ãŠã ã»ã
ã«ã«ãªã¢MTâïŒæ ªïŒMyrothecium verrucaria
MTâïŒïŒãå¹é€æ¶²äžã«ããªã«ãã³ã»ãªãã·ã
ãŒãŒãçç£ããããšãèŠåºããã粟補é
µçŽ ã¯ããª
ã«ãã³ãé
žåããŠããªãã«ãžã³ãçæããããšã
å ±åãããŠãããã¢ã°ãªã«ã«ããŠã©ã«ã»ã¢ã³ãã»
ãã€ãªããžã«ã«ã»ã±ãã¹ããªãŒïŒAgric.Biol.
Chem.ïŒç¬¬45巻第2385é ïŒ1981幎ïŒãã
æ¬çºæè
ãã¯ãæ
åèã®çç£ããããªã«ãã³ã»
ãªãã·ããŒãŒã«ã€ããŠéææ€èšãéããçµæãã
ãçš®ã®æ
åèãå¹é€æ¶²äžã«èéã®ããªã«ãã³ã»ãª
ããžããŒãŒãçç£ããããšãèŠåºããã®ã§ãæ¬é
µ
çŽ ã粟補ãè«žæ§è³ªãæ€èšããããã®çµæãæ¬é
µçŽ
ã¯æ¢ã«å ±åãããŠããããªã«ãã³ã»ãªãã·ããŒãŒ
ãšã¯ç°ãªãæ°èŠãªããªã«ãã³ã»ãªãã·ããŒãŒã§ã
ããšããçµè«ã«è³ã€ãã
æ¬çºæã«äœ¿çšãããæ
åèã¯ãšãã¿ã±å±ã«å±ã
ãèæ ªã§ãããäŸãã°ãšãã¿ã±ããã©ããã«ãã»
ããããšïŒ«â2593ïŒTrachyderma tsunodae â
2593ïŒãã§ãããæ¬èæ ªã¯1977幎ïŒæé³¥åç倧山
ã«ãŠããã®æ¯å¹¹äžã«çããŠããåå®äœããåé¢ã
ããã
æ¬èæ ªã®åå®äœããã³èåã®åœ¢æ
çç¹åŸŽã¯ä»¥äž
ã®ãšããã§ããã
ïŒå¹Žçã§ç¡æãåã¯æå¹³ãŸãã¯äœã䞞山圢ãå
å圢ã§ãããïŒã15ÃïŒã15cmãè¡šé¢ã¯å
æ²¢ãªã
æ¿ãããã±ã€è²ã§ã现ããçºãšç²ç¶ã®ç¡¬ãçªèµ·ã§
ãããããŠç²èã§ãããéåžžãããšã³ã¬ãŒãè²ã®
èåã§ãããããŠãããèã¯çè²äžã¯æè»åŒ·é±
ã§ã也ç¥ãããšæ¥µããŠç¡¬ãæšè³ªã«ãªããèã®è²ã¯
ã»ãŒçœè²ã§ãããäžé¢ã¯ã»ãŒçœè²ã§ãåŸã«æ±è€è²
ãšãªãã管åã¯é·ãçŽ1.5cmã§ãæ·¡ãããã±ã€è²ã
åå£ã¯åŸ®çŽ°ã§ãããèåã¯ãžã€ããã«ã
ïŒGanodermaïŒåãåºåµåœ¢ã§å€§ããã20ã24Ã14
ã16.5ÎŒãæ·¡é»è²ãå
å€ã®èã¯æçã§ããã以äž
ã®ç¹åŸŽãä»é¢å
ä¹ãæ¬é·æ¬¡éå
±èãæ£ã»ç¶åè²æ¥
æ¬èé¡å³éãä¿è²ç€Ÿåºçããã³äŒè€èª ä¹èãæ¥æ¬
èé¡èªç¬¬ïŒå·»ç¬¬ïŒå·ã1955幎é€è³¢å åºçã®èšèŒãš
æ¯èŒãããšãæ¬èã¯ãšãã¿ã±ã§ããããšãæçã§
ãããæ¬èã¯å·¥æ¥æè¡é¢åŸ®çç©å·¥æ¥æè¡ç 究æã«
埮çç©åèšçªå·åŸ®å·¥ç æ¡å¯ç¬¬387å·ãšããŠå¯èšã
ããŠããã
æ¬çºæãæŽã«è©³ãã説æããã°ãå¹å°ã«å ãã
æ é€æºã¯äœ¿çšããèæ ªãå©çšãåŸããã®ã§ããã°
ãããççŽ æºãšããŠã¯äŸãã°ã°ãªã»ããŒã«ãã°ã«
ã³ãŒã¹ããã³ãã³ãã·ãŠã¯ããŒã¹ããã«ããŒã¹ã
ã©ã¯ããŒã¹ãããã¹ããªã³ãæ²¹èé¡ãªã©ãå©çšã§
ããçªçŽ æºãšããŠã¯é
µæ¯ãšãã¹ããããã³ãã³ãŒ
ã³ã¹ãã€ãŒããªã«ãŒãè±è倧è±ã倧è±ç²ãèãšã
ã¹ãªã©ãé©åœã§ããããã®ä»ã«ãªã³é
žå¡©ãã«ãªãŠ
ã å¡©ããã°ãã·ãŠã å¡©ãªã©ã®ç¡æ©è³ªããã³éå±å¡©
é¡ãå ããŠãããããªããæ¬çºæã®æ°èŠããªã«ã
ã³ã»ãªãã·ããŒãŒã¯é
é
µçŽ ã§ããæ
ãç¡«é
žé
ãå¹
å°ã«æ·»å ããã°èããé
µçŽ çç£éãå¢å€§ãããäŸ
ãã°5ppmã®æ·»å ã«ããç¡æ·»å ã«æ¯ã¹ãŠïŒã10å
ã®æ¬çºæã«ããæ°èŠããªã«ãã³ã»ãªãã·ããŒãŒã
çç£ãããã
æ
åèãå¹é€ããã«ããããæ¬çºæã«ããæ°èŠ
ããªã«ãã³ã»ãªãã·ããŒãŒã®çç£éã¯å¹é€æ¡ä»¶ã«
ãã倧ããå€åããããäžè¬ã«å¹é€æž©åºŠã¯20ã25
âãå¹å°ã®PHïŒãïŒãè¯ããïŒã15æ¥éã®éæ°æ¹
æå¹é€ã§æ¬çºæã«ããæ°èŠããªã«ãã³ã»ãªãã·ã
ãŒãŒã®çç£ã¯æé«ã«éãããå¹é€æ¡ä»¶ã¯äœ¿çšãã
èæ ªãå¹å°çµæãªã©ã«å¿ããæ°èŠããªã«ãã³ã»ãª
ãã·ããŒãŒã®çç£éãæ倧ã«ãªãããã«èšå®ãã
ã®ã¯åœç¶ã§ããã
æ¬çºæã®èã«ãã€ãŠçæãããæ°èŠããªã«ã
ã³ã»ãªãã·ããŒãŒã¯å¹é€æ¶²äžã«ãããå¹é€æ¶²ã«
ææ©æº¶åªäŸãã°ã¢ã«ã³ãŒã«ãã¢ã»ãã³ãªã©ã50ã
80vïŒïœïŒ
å ããããšã«ããããããã¯æ²æ®¿å€äŸ
ãã°ç¡«å®ã20ã60wïŒïœïŒ
å ããããšã«ããæ²æ®¿
ãšããŠåé¢ããããåŸãããæ²æ®¿ç©ããéæãã
ãã¯ã»ãã¢ããã¯ã¹åŠçã«ãã€ãŠè±å¡©ããç²é
žçŽ
液ãåŸããåŸãããç²é
µçŽ 液ã粟補ããã«ã¯ãã
ãããã0.03Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§ç·©è¡å
ãããDEAEâã»ãã¢ããã¯ã¹ïŒïŒ¡â50ïŒã®ã«ã©
ã ã«åžçãããåžçç©ã0.1Mãªã³é
žç·©è¡æ¶²ïŒPH
7.0ïŒã§æŽæ»åŸã0.3Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§æº¶
åºããŠæŽ»æ§åºåãéããã次ã«ãã®æŽ»æ§åºåãé
å€éã§æ¿çž®ãè±å¡©åŸã0.03Mãªã³é
žç·©è¡æ¶²ïŒPH
7.0ïŒã§ç·©è¡åããDEAEã»ã»ãã¢ããŒã¹ïŒCLâ
6BïŒã®ã«ã©ã ã«åžçãããåžçç©ã0.1Mãªã³é
ž
ç·©è¡æ¶²ïŒPH7.0ïŒã§æŽæ»æ¶²ã0.2Mãªã³é
žç·©è¡æ¶²
ïŒPH7.0ïŒã§æº¶åºããŠæŽ»æ§åºåãéããããã®æŽ»æ§
åºåãã³ããžãªã³èã§æ¿çž®åŸãããããã0.1M
ãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§ç·©è¡åããã»ãã¢ã¯ãª
ã«ïŒ³â200ã®ã«ã©ã ã§ã²ã«éãè¡ãªããåŸã掻
æ§åºåã0.01Mã®ãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã«éæ
åŸãåçµä¹Ÿç¥ãã粟補é
µçŽ ç²æ«ãåŸãããã®é
µçŽ
ç²æ«ã¯ããªã¢ã¯ãªã«ã¢ããã²ã«ãã€ã¹ã¯é»æ°æ³³å
çã«åäžã§ããã
æ¬çºæã«ããåŸãããæ°èŠããªã«ãã³ã»ãªãã·
ããŒãŒã®é
µçŽ ååŠçããã³çååŠçæ§è³ªã¯æ¬¡ã®ãš
ããã§ããã
(1) äœçšïŒ
æ¬çºæã®é
µçŽ ã¯ãé
žçŽ ã®ååšäžãããªã«ãã³
ãé
žåãããªãã«ãžã³ã淡玫è²ç©è³ªãçµãŠãã»
ãŒç¡è²ã®ç©è³ªãçæããäœçšãæããããéé
ž
åæ°ŽçŽ ãçæããªãã
(2) åºè³ªç¹ç°æ§ïŒ
ããªã«ãã³ã«äœçšãããããªãã«ãžã³ã«ãè¥
å¹²äœçšããããããªã«ãã³ã®é
žåé床ã®çŽïŒïŒ
ã§ããããŸããããšããŒã«ãã«ãã³ãŒã«ããã€
ããããã³ãªã©ã«ãäœçšãããããã¢ã°ãã
ã³ããã¿ãã³B12ã«ã¯äœçšããªãã
(3) é
µçŽ 掻æ§æž¬å®æ³ïŒ
é
µçŽ 掻æ§ã®æž¬å®ã¯ããªã«ãã³ã®460nïœã®åž
åã®æžå°ããæ±ãããå³ã¡ããªã¡ã¬é«ããªã«ã
ã³ã³ã³ãããŒã«è¡æž
ïŒç±³åœãã€ã©ã³ã瀟補ïŒ
0.1mlããªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒ300ÎŒmolããã³
é©åœã«åžéããé
µçŽ 液0.1mlãåå¿æ¶²é3.0mlã§
37âã10åéåå¿ãããããªã«ãã³ã«åºã¥ã
460nïœã®åžåæžå°ã枬å®ãããæ°èŠããªã«ã
ã³ã»ãªãã·ããŒãŒïŒåäœã¯37âã§ïŒåéã«
460nïœã«ãããåžåã1.00æžå°ãããé
µçŽ éãš
ããŠè¡šç€ºããã
(4) è³é©PHããã³PHå®å®æ§ïŒ
æ¬é
µçŽ ã®è³é©PHã¯ç¬¬ïŒå³ã®æ²ç·ã§è¡šãããã
ãããšãPH5.5ä»è¿ã«æ¥µããŠé«ã掻æ§ãæããŠ
ãããæ¬é
µçŽ ã37âã«ãããŠããããã®PHã§60
åéåŠçãããšãã®PHå®å®æ§ã第ïŒå³ã«ç€ºã
ãã第ïŒå³ããæãããªããã«æ¬é
µçŽ ã¯PHïŒã
PHïŒã®éã§å®å®ã§ããã
(5) è³é©æž©åºŠããã³ç±å®å®æ§ïŒ
æ¬é
µçŽ ã®è³é©æž©åºŠã¯ç¬¬ïŒå³ã®æ²ç·ã§è¡šããã
ãããšã50âä»è¿ã«è³é©æž©åºŠãæããŠãããæ¬
é
µçŽ ãPH7.0ã«ãããŠããããã®æž©åºŠã§10åé
åŠçãããšãã®ç±å®å®æ§ã第ïŒå³ã«ç€ºãããæ¬
é
µçŽ ã¯55âãŸã§å®å®ã§ãã€ãã
(6) ååéïŒ
æ¬é
µçŽ ã®ååéã¯ãã»ãã¢ã¯ãªã«ïŒ³â200ïŒã
ã¢ã«ãã·ã¢è£œïŒã«ããã²ã«éæ³ã§ã¯çŽ83000
ã§ãã€ãã
(7) åäžæ§ïŒ
7.5ïŒ
ããªã¢ã¯ãªã«ã¢ããã²ã«ïŒPH9.4ïŒãçš
ããŠãã€ã¹ã¯é»æ°æ³³åãè¡ãªã€ããïŒæ¬æ³³å
ããäžæ¹ã¯ã¿ã³ãã¯æè²ãããšããïŒæ¬ã®æè²
垯ãèªãããåäžã§ãã€ããããäžæ¹ã¯æŽ»æ§æ
è²ãè¡ãªã€ããæ¬é
µçŽ ã¯ïŒâã¢ããã¢ã³ãããª
ã³ããã³ããšããŒã«ãå®éçã«èµ€è²ã«çºè²ãã
ãäœçšãæããŠããããã®çµæãã¿ã³ãã¯æè²
ã®äœçœ®ãšæŽ»æ§æè²ã®äœçœ®ãå
šãäžèŽããã
(8) çé»ç¹ïŒ
ãã¢ã«ãã©ã€ãïŒPHïŒã10ããã¢ã«ãã·ã¢
補ïŒãçšããçŠç¹é»æ°æ³³åããæ±ããæ¬é
µçŽ ã®
çé»ç¹ã¯3.92±0.05ã§ãã€ãã
(9) éå±ã€ãªã³ãé»å®³å€ãªã©ã®åœ±é¿ïŒ
æ¬é
µçŽ ã¯ç¬¬ïŒè¡šã«ç€ºãããã«ãCu2+ãâ
ã¢ã¹ã³ã«ãã³é
žã«ãã匷åã«é»å®³ãããããŸ
ãããžããªã¹ã¬ã€ããŒã«ãã·ã¢ã³åã«ãªãŠã ã
âã·ã¹ãã€ã³ããããªãŠã ã¢ãžããEDTAã
Fe2+ãªã©ã«ãã€ãŠãããªãé»å®³ãããã
第ïŒè¡š
æ·»å ç©ïŒïŒïœïŒïŒ é»å®³çïŒïŒ
ïŒ
Fe2+ 57
Cu2+ 100
ãããªãŠã ã¢ãžã 60
ããªå°¿çŽ ïŒ
ïœâããšãã³ã¹ããªã³ 34
αïŒÎ±â²âãžããªãžã« 30
âã¢ã¹ã³ã«ãã³é
ž 100
ãšãŒãé
¢é
ž 10
ãžããªã¹ã¬ã€ããŒã« 86
âã·ã¹ãã€ã³ 74
ïŒâã¡ã«ã«ãããšã¿ããŒã« 31
ã·ã¢ã³åã«ãªãŠã 84
éå
åã°ã«ã¿ããªã³ 38
EDTA 59
(10) å¯èŠéšåžåã¹ãã¯ãã«ïŒ
æ¬é
µçŽ 溶液ã®å¯èŠéšåžåã¹ãã¯ãã«ã枬å®ã
ããšããã610nïœã«æ¥µå€§ãèªããããã«ãŒã¿
ã³ãã¯ã§ãã€ãã
(11) ç³å«éïŒ
7.5ïŒ
ããªã¢ã¯ãªã«ã¢ããã²ã«ïŒPH9.4ïŒãçš
ããŠããã€ã¹ã¯é»æ°æ³³åãè¡ãªããPASæè²
ïŒã¢ããªãã€ã«ã«ã»ãã€ãªã±ãã¹ããªãŒ
ïŒAnal.Biochem.ïŒç¬¬30巻第148é ïŒ1969幎ïŒã
ãè¡ãªã€ããšãããã¿ã³ãã¯æè²äœçœ®ãšåäžéš
åãæè²ãããããã®ããšãããæ¬é
µçŽ ã¯ç³ã
å«ãç³ã¿ã³ãã¯ã§ããããšãããããããã§ã
ç³å«éãããšããŒã«ã»ç¡«é
žæ³ã§æž¬å®ãããšãã
çŽ4.5ïŒ
ã§ãã€ãã
(12) é
å«éïŒ
åååžå
åææ©ãçšããŠãæ¬é
µçŽ äžã®é
ã®å®
éãè¡ãªã€ããšãããé
žçŽ ïŒã¢ã«ã«å¯ŸããŠïŒã¢
ã«ã®é
ãå«ãŸããŠããã
以äžæ¬çºæã«ããé
µçŽ ãåŸæ¥ã®ããªã«ãã³ã»ãª
ãã·ããŒãŒãšæ¯èŒãããšã第ïŒè¡šã®ããšãã§ã
ãã
The present invention relates to the basidiomycete, Trachyderma spp.
This invention relates to a novel bilirubin oxidase produced by and a method for producing the same. Bilirubin is a yellow substance produced in blood by the decomposition of hemoglobin, and rapid and accurate detection of bilirubin in serum is very important for medically diagnosing human disease conditions (e.g. jaundice). It is. That is, in patients with jaundice, bilirubin in serum increases abnormally, so the degree of jaundice can be diagnosed by measuring bilirunin in serum. Bilirubin oxidase is used to quantify bilirubin in serum, but this enzyme is also used to remove bilirubin, which can cause errors in measurement values when analyzing analytes other than bilirubin. Useful. When measuring glucose or cholesterol in serum, the most commonly used daily test method is the colorimetric method in which glucose oxidase, cholesterol oxidase, etc. are applied to the serum and the generated hydrogen peroxide is captured using peroxidase. . In particular, the coloring method using 4-aminoantipyrine-phenol has become the mainstream enzymatic method because it is simple and rapid, and the reagent is stable. Although this colorimetric method measures the red quinone pigment produced at 500 nm, the presence of bilirubin in serum gives a negative error. Therefore, if bilirubin oxidase is applied to serum in advance to remove bilirubin, and then glucose oxidase or cholesterol oxidase is applied to serum, accurate glucose or cholesterol values in serum can be obtained. Regarding bilirubin oxidase, R.
First reported by R. Brodersen and P. Bortels [Europ.J.Biochem, Vol. 10, No. 468]
Page (1969)]. They reported that bilirubin is oxidized to biliverdin by an insoluble bilirubin oxidase isolated from guinea pig brain. Furthermore, it has been reported that the fungal juice of Agaricus bisporus, a type of mushroom, has oxygen activity that oxidizes bilirubin and produces hydrogen peroxide (Japanese Patent Publication No. 11194/1982). moreover,
Recently, Myrothecium verrucaria strain MT-1 (Myrothecium verrucaria, which belongs to the genus Myrothecium)
MT-1) was found to produce bilirubin oxidase in the culture medium, and it has been reported that the purified enzyme oxidizes bilirubin to produce biliverdin [Agricultural &
Biological Chemistry (Agric.Biol.
Chem.) Vol. 45, p. 2385 (1981)]. The present inventors discovered that bilirubin produced by basidiomycetes
As a result of extensive research into oxidase, we discovered that a certain type of basidiomycete produces a significant amount of bilirubin oxidase in its culture solution, so we purified this enzyme and examined its properties. As a result, we came to the conclusion that this enzyme is a novel bilirubin oxidase that is different from previously reported bilirubin oxidases. The basidiomycetes used in the present invention are strains belonging to the genus Ebitake, such as Ebitake [trachyderma
Trachyderma tsunodae K-2593 (Trachyderma tsunodae K-
2593)]. This bacterial strain was isolated from a fruiting body growing on a dead beech trunk in Daisen, Tottori Prefecture, in August 1977. The morphological characteristics of the fruiting body and spores of this strain are as follows. A first-year-old, sessile, the cap is flat or low in the shape of a round mountain, semicircular, 5-15 x 3-15 cm, the surface is dark, dark red, and rough, with no luster and covered with fine wrinkles and granular hard protrusions. . Usually covered with cyokolate-colored spores. The flesh is flexible and tough while growing, and becomes extremely hard and woody when dried. The color of the flesh is almost white. The underside is almost white, later becoming dark brown. The tube hole is about 1.5 cm long and has a light yellow color.
The pores are minute. Spores are Ganoderma type, broadly ovoid and large, 20-24 x 14
~16.5Ό, pale yellow, inner and outer membranes clear. Comparing the above characteristics with the descriptions in ``Illustrated Encyclopedia of Japanese Fungi in True and Continued Primary Colors,'' co-authored by Rokuya Imazeki and Tsuguo Hongo, published by Yokyusha Publishing, and ``Japanese Mycological Journal Vol. 2, No. 4'' by Seiya Ito, published in 1955 by Yokendo Publishing. , it is clear that this bacterium is Ebitake. This bacterium has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology under microorganism accession number 387. To explain the present invention in more detail, the nutrient source added to the medium may be any one that can be used by the strain used, and the carbon source may include, for example, glycerol, glucose, starch, sucrose, maltose,
Lactose, dextrin, fats and oils, etc. can be used, and suitable nitrogen sources include yeast extract, peptone, cornstarch liquor, defatted soybeans, soy flour, and meat extract. In addition, inorganic and metal salts such as phosphates, potassium salts, and magnesium salts may be added. In addition, since the novel bilirubin oxidase of the present invention is a copper enzyme, adding copper sulfate to the medium significantly increases the amount of enzyme production. For example, by adding 5 ppm, 5 to 10 times more of the novel bilirubin oxidase according to the present invention is produced than when no addition is made. When culturing basidiomycetes, the production amount of the novel bilirubin oxidase according to the present invention varies greatly depending on the culture conditions, but in general, the culture temperature is 20 to 25â.
â, the pH of the medium is preferably 4 to 7, and the production of the novel bilirubin oxidase according to the present invention reaches its maximum after 3 to 15 days of aeration and agitation culture. It goes without saying that the culture conditions should be set so as to maximize the production of new bilirubin oxidase depending on the bacterial strain used, medium composition, etc. The novel bilirubin oxidase produced by the bacterium of the present invention is present in a culture solution, and the culture solution is mixed with an organic solvent such as alcohol, acetone, etc.
It is separated as a precipitate by adding 80% v/v or by adding a precipitant such as ammonium sulfate from 20 to 60% w/v. The obtained precipitate is desalted by dialysis or sepadex treatment to obtain a crude oxygen solution. To purify the obtained crude enzyme solution, it was buffered in advance with 0.03M phosphate buffer (PH7.0). The adsorbed material was adsorbed onto a column of DEAE-Sephadex (A-50), and the adsorbed material was dissolved in 0.1M phosphate buffer (PH
After washing with 7.0), elute with 0.3M phosphate buffer (PH7.0) and collect the active fraction. Next, this active fraction was concentrated by ultrafiltration, desalted, and then added to 0.03M phosphate buffer (PH
DEAE/Sepharose (CLâ) buffered with 7.0)
6B), wash the adsorbed material with 0.1M phosphate buffer (PH7.0), elute with 0.2M phosphate buffer (PH7.0), and collect the active fraction. After concentrating this active fraction with a collodion membrane, 0.1M
Gel filtration was performed using a Sephacryl S-200 column buffered with phosphate buffer (PH7.0), and the obtained active fraction was dialyzed against 0.01M phosphate buffer (PH7.0), and then freeze-dried. Obtain purified enzyme powder. This enzyme powder is electrophoretically homogeneous on polyacrylamide gel discs. The enzymatic and physicochemical properties of the novel bilirubin oxidase obtained by the present invention are as follows. (1) Action: The enzyme of the present invention has the action of oxidizing bilirubin in the presence of oxygen to produce an almost colorless substance via biliverdin, a pale purple substance, but does not produce hydrogen peroxide. (2) Substrate specificity: Acts on bilirubin. It also has a slight effect on biliverdin, but it accounts for about 1% of the oxidation rate of bilirubin.
It is. It also acts on phenol, catechol, and hydroquinone, but not on hemoglobin or vitamin B12 . (3) Enzyme activity measurement method: Enzyme activity was determined by decreasing the absorption of bilirubin at 460 nm. Namely, Omega High Bilirubin Control Serum (manufactured by Highland, Inc., USA)
0.1 ml, 300 ÎŒmol of phosphate buffer (PH7.0), 0.1 ml of appropriately diluted enzyme solution, and 3.0 ml of reaction solution.
Based on bilirubin, reacted for 10 minutes at 37°C
Absorption reduction at 460 nm was measured. One unit of new bilirubin oxidase per minute at 37â
It is expressed as the amount of enzyme that reduces the absorption at 460 nm by 1.00. (4) Optimal PH and PH stability: The optimal PH of this enzyme was around PH5.5, as shown by the curve in Figure 1, and it had extremely high activity. This enzyme was incubated at 37°C at each pH of 60%.
Figure 3 shows the PH stability when treated for minutes. As is clear from Figure 3, this enzyme has a pH of 5~
Stable between pH9. (5) Optimal temperature and thermostability: The optimal temperature of this enzyme is around 50°C, as shown by the curve in Figure 2. Figure 4 shows the thermal stability of this enzyme when it was treated at pH 7.0 for 10 minutes at each temperature. This enzyme was stable up to 55°C. (6) Molecular weight: The molecular weight of this enzyme is approximately 83,000 when measured by gel filtration using Sephacryl S-200 (manufactured by Pharmacia).
It was hot. (7) Homogeneity: Disk electrophoresis was performed using 7.5% polyacrylamide gel (PH9.4). When two gels were run and one was stained for protein, a single stained band was observed. The other was subjected to activity staining. This enzyme has the effect of quantitatively developing red color from 4-aminoantipyrine and phenol. As a result, the positions of protein staining and activity staining completely matched. (8) Isoelectric point: The isoelectric point of the enzyme determined by focal electrophoresis using Pharmalite (PH3-10, manufactured by Pharmacia) was 3.92±0.05. (9) Effects of metal ions, inhibitors, etc.: As shown in Table 1 , this enzyme
It was strongly inhibited by ascorbic acid. Also, dithiothreitol, potassium cyanide,
L-cysteine, sodium azide, EDTA,
It was also significantly inhibited by Fe 2+ etc. Table 1 Additive (1mM) Inhibition rate (%) Fe 2+ 57 Cu 2+ 100 Sodium azide 60 Thiourea 0 o-phenanthroline 34 α,αâ²-dipyridyl 30 L-ascorbic acid 100 Iodoacetic acid 10 Dithiothreitol 86 L-cysteine 74 2-mercaptoethanol 31 Potassium cyanide 84 Reduced glutathione 38 EDTA 59 (10) Visible absorption spectrum: When the visible absorption spectrum of this enzyme solution was measured, a maximum was observed at 610 nm, indicating that it was blue protein. (11) Sugar content: Perform disc electrophoresis using 7.5% polyacrylamide gel (PH9.4) and PAS staining (Analytical Biochem. Vol. 30, p. 148 (1969))
When this was performed, the same area as the protein staining position was stained. This indicates that this enzyme is a glycoprotein containing sugar. Therefore,
The sugar content was measured using the phenol/sulfuric acid method and was approximately 4.5%. (12) Copper content: When the amount of copper in this enzyme was determined using an atomic absorption spectrometer, it was found that 4 mol of copper was contained per 1 mol of oxygen. A comparison of the enzyme according to the present invention with conventional bilirubin oxidase is as shown in Table 2.
ãè¡šããtableã
ãè¡šã
以äžã«æ¬çºæã«ããæ°èŠããªã«ãã³ã»ãªãã·ã
ãŒãŒã®è£œé æ¹æ³ãå®æœäŸããã€ãŠç€ºãããæ¬çºæ
ã以äžã®å®æœäŸã®ç¯å²ã®ã¿ã«éå®ããããã®ã§ã¯
ãªãã
å®æœäŸ ïŒ
ã°ã«ã³ãŒã¹ïŒïŒ
ããšããªã¹0.5ïŒ
ããã³å¯å€©1.5
ïŒ
ïŒãšããªã¹å¹å°ïŒã®çµæã®æé¢å¹å°ã«ãã©ãã
ã«ãã»ããããšïŒ«â2593ãæ¥çš®ãã25âã«ãŠïŒé±
éé眮å¹é€ããŠçš®èãšãããã°ãªã»ããŒã«2.0ïŒ
ã
é
µæ¯ãšãã¹0.3ïŒ
ããããã³ïŒïŒ
ãKH2PO40.3ïŒ
ã
MgSO4ã»7H2O0.1ïŒ
ããã³CuSO4ã»5H2O5ppm
ã®çµæã®å¹å°100mlã500ml容ã®äžè§ãã©ã¹ã³ã«å
泚ãã120âã§20åé殺èåŸãå·åŽããããã«äž
èšã®çš®èããããšãæ¥çš®ããŠã27âã§10æ¥éãæ¯
å100å転ã§æ¯çªå¹é€ãããå¹é€çµäºåŸéããŠ
èäœãé€ããéãåŸãããã®æ°èŠããªã«ãã³ã»
ãªãã·ããŒãŒæŽ»æ§ã¯15.0åäœïŒmlã§ãã€ãã
å®æœäŸ ïŒ
å®æœäŸïŒã®ãšããªã¹å¹å°ã§å¹é€ãããã©ããã«
ãã»ããããšïŒ«â2593ãã°ãªã»ããŒã«ïŒïŒ
ãé
µæ¯
ãšãã¹0.3ïŒ
ããããã³ïŒïŒ
ãKH2PO40.3ïŒ
ãã
ã³MgSO4ã»7H2O0.1ïŒ
ã®å¹å°100mlãå泚ããŠæ®º
èïŒ120âã20åéïŒãã500ml容ã®äžè§ãã©ã¹ã³
ã«æ¥çš®ãã27âã§ïŒæ¥éå¹é€ããŠãçš®å¹é€æ¶²ãšã
ããã°ãªã»ããŒã«ïŒïŒ
ãé
µæ¯ãšãã¹0.3ïŒ
ããã
ãã³ïŒïŒ
ãKH2PO40.3ïŒ
ãMgSO4ã»7H2O0.1ïŒ
ã
CuSO4ã»5H2O5ppmããã³æ¶æ³¡å€ïŒæ¥æ¬æ²¹è瀟
補CBâ442ïŒ0.03ïŒ
ã®çµæã®å¹å°20ã30容ã®
ãžã€ãŒãã¢ãŒã¡ã³ã¿ãŒã«å
¥ãã120âã§20åé殺
èãããå·åŽåŸäžèšã®çš®å¹é€æ¶²100mlãæ¥çš®ãã
27âã§ïŒæ¥éãæ¯å20ã®éæ°é床ãšæ¯å250å
転ã®æ¹æé床ã®æ¡ä»¶ã§å¹é€ãããå¹é€çµäºåŸã
éããŠèäœãé€ããéãåŸãããã®æ°èŠããªã«
ãã³ã»ãªãã·ããŒãŒæŽ»æ§ã¯21.5åäœïŒmlã§ãã€
ãããã®å¹é€æ¶²17ã«ç¡é
žã¢ã³ã¢ããŠã ã60ïŒ
飜åã«ãªãããã«å ããŠãäžæŒå€æŸçœ®åŸãåŸãç¡«
å®æ²æ®¿ç©ã倧éã®0.03Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒ
ã«å¯ŸããŠãäžæŒå€éæãããåŸãããç²é
µçŽ 液
ããããããã0.03Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§
ç·©è¡åããDEAEâã»ãã¢ããã¯ã¹ïŒïŒ¡â50ïŒã®
ã«ã©ã ïŒÏ11.0cmÃ10cmïŒã«åžçãããåžçç©ã
0.1Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§æŽæ»æ¶²ã0.3Mãªã³
é
žç·©è¡æ¶²ïŒPH7.0ïŒã§æº¶åºãã掻æ§åºåãéå€
éã§æ¿çž®ãè±å¡©åŸã0.03Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒ
ã§ç·©è¡åããDEAEâã»ãã¢ããŒã¹ïŒCLâ6BïŒ
ã®ã«ã©ã ïŒÏ5.0cmÃïŒcmïŒã«åžçãããåžçç©ã
0.1Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§æŽæ»åŸã0.2Mãªã³
é
žç·©è¡æ¶²ïŒPH7.0ïŒã§æº¶åºããŠæŽ»æ§åºåãéããã
ãã®æŽ»æ§åºåãã³ããžãªã³èã§æ¿çž®åŸããããã
ã0.1Mãªã³é
žç·©è¡æ¶²ïŒPH7.0ïŒã§ç·©è¡åããã»ã
ã¢ã¯ãªã«ïŒ³â200ã®ã«ã©ã ïŒÏ3.6cmÃ90cmïŒã§ã²
ã«éãè¡ãªããåŸã掻æ§åºåã0.01Mã®ãªã³é
ž
ç·©è¡æ¶²ïŒPH7.0ïŒã«éæåŸãå®å®å€ãšããŠã·ãŠã¯
ããŒã¹ãæçµæ¿åºŠ0.1ïŒ
ã«ãªãããã«å ããŠåçµ
也ç¥ãã粟補é
µçŽ ç²æ«760mgãåŸãããã®ç²æ«ã®
æ¯æŽ»æ§ã¯355åäœïŒmgã§ãã€ãããã®é
µçŽ ç²æ«ã¯
ããªã¢ã¯ãªã«ã¢ããã²ã«ãã€ã¹ã¯é»æ°æ³³åçã«å
äžã§ãã€ãã以äžã®ç²Ÿè£œå·¥çšã第ïŒè¡šã«ç€ºãã[Table] The method for producing the novel bilirubin oxidase according to the present invention is shown below with examples, but the present invention is not limited to the scope of the following examples. Example 1 Glucose 2%, Ebios 0.5% and Agar 1.5
Trachyderma tsunodae K-2593 was inoculated into a slant medium having a composition of % (Ebios medium), and cultured stationary at 25° C. for one week to prepare a seed culture. glycerol 2.0%,
Yeast extract 0.3%, peptone 1%, KH 2 PO 4 0.3%,
MgSO4ã»7H2O0.1 % and CuSO4ã»5H2O5ppm
Dispense 100 ml of a medium with the composition into a 500 ml Erlenmeyer flask, sterilize it at 120°C for 20 minutes, cool it, inoculate it with the above inoculum, and shake at 100 revolutions per minute at 27°C for 10 days. Cultured. After the culture was completed, the bacterial cells were removed to obtain a filtrate. This new bilirubin
Oxidase activity was 15.0 units/ml. Example 2 Trachyderma tsunodae K-2593 cultured in the Ebios medium of Example 1 was cultured in a medium containing 2% glycerol, 0.3% yeast extract, 1% peptone, 0.3% KH 2 PO 4 and 0.1% MgSO 4 7H 2 O. 100 ml was dispensed and inoculated into a 500 ml Erlenmeyer flask that had been sterilized (120°C, 20 minutes), and cultured at 27°C for 7 days to prepare a seed culture. Glycerol 2%, yeast extract 0.3%, peptone 1%, KH 2 PO 4 0.3%, MgSO 4 7H 2 O 0.1%,
Medium 20 containing 5 ppm of CuSO 4 .5H 2 O and 0.03% antifoaming agent (CB-442 manufactured by Nihon Yushi Co., Ltd.) was placed in a 30 volume jar fermenter and sterilized at 120° C. for 20 minutes. After cooling, inoculate 100ml of the above seed culture solution,
Culture was carried out at 27° C. for 7 days at an aeration rate of 20 rpm and a stirring rate of 250 revolutions per minute. After culturing,
The bacterial cells were removed by filtration to obtain a filtrate. The new bilirubin oxidase activity was 21.5 units/ml. Add 60% ammonium nitrate to this culture solution 17.
Add the ammonium sulfate precipitate to saturation and leave it overnight, then add the ammonium sulfate precipitate to a large amount of 0.03M phosphate buffer (PH7.0).
I underwent dialysis all day and night. The obtained crude enzyme solution was adsorbed onto a column (Ï11.0cm x 10cm) of DEAE-Sephadex (A-50) buffered in advance with 0.03M phosphate buffer (PH7.0), and the adsorbed material was
The active fraction was washed with 0.1M phosphate buffer (PH7.0) and eluted with 0.3M phosphate buffer (PH7.0), concentrated by ultrafiltration, desalted, and washed with 0.03M phosphate buffer (PH7.0). .0)
DEAE-Sepharose (CL-6B) buffered with
Column (Ï5.0cm x 5cm) to adsorb the adsorbed material.
After washing with 0.1M phosphate buffer (PH7.0), active fractions were collected by elution with 0.2M phosphate buffer (PH7.0).
After concentrating this active fraction using a collodion membrane, gel filtration was performed using a Sephacryl S-200 column (Ï3.6 cm x 90 cm) buffered in advance with 0.1 M phosphate buffer (PH7.0), and the obtained active fraction was concentrated. After dialysis against 0.01M phosphate buffer (PH7.0), sucrose was added as a stabilizer to a final concentration of 0.1% and freeze-dried to obtain 760 mg of purified enzyme powder. The specific activity of this powder was 355 units/mg. This enzyme powder was uniform in polyacrylamide gel disc electrophoresis. The above purification steps are shown in Table 3.
第ïŒå³ã¯æ¬çºæã«ããåŸãããæ°èŠããªã«ã
ã³ã»ãªãã·ããŒãŒã®PHãšæŽ»æ§ã®é¢ä¿ãè¡šããã第
ïŒå³ã¯æž©åºŠãšæŽ»æ§ã®é¢ä¿ãè¡šããã第ïŒå³ã¯æ°èŠ
ããªã«ãã³ã»ãªãã·ããŒãŒã37âã«ãããŠããã
ãã®PHã§60åéåŠçããåŸã®PHãšæŽ»æ§ã®é¢ä¿ãè¡š
ããã第ïŒå³ã¯PH7.0ã«ãããŠããããã®æž©åºŠã§
10åéåŠçããåŸã®æž©åºŠãšæŽ»æ§ã®é¢ä¿ãè¡šããã
FIG. 1 shows the relationship between PH and activity of the novel bilirubin oxidase obtained by the present invention, and FIG. 2 shows the relationship between temperature and activity. Figure 3 shows the relationship between PH and activity after the novel bilirubin oxidase was treated at 37°C for 60 minutes at each PH, and Figure 4 shows the relationship between PH and activity at PH7.0 and at each temperature.
It shows the relationship between temperature and activity after treatment for 10 minutes.
Claims (1)
ãªãã·ããŒãŒã (1) äœçšïŒé žçŽ ã®ååšäžãããªã«ãã³ãé žåãã
ããªãã«ãžã³ã淡玫è²ç©è³ªãçµãŠã»ãŒç¡è²ã®ç©
質ãçæããäœçšãæããããéé žåæ°ŽçŽ ãç
æããªãã (2) åºè³ªç¹ç°æ§ïŒããªã«ãã³ã«äœçšãããããªã
ã«ãžã³ã«ã¯è¥å¹²äœçšããããŸããããšããŒã«ã
ã«ãã³ãŒã«ããã€ããããã³ãªã©ã«ãäœçšã
ãã (3) è³é©PHããã³PHå®å®æ§ïŒè³é©PHã5.5ä»è¿ã§
ããã37âã60åéåŠçã§ã¯PHïŒãPHïŒã®éã§
å®å®ã§ããã (4) è³é©æž©åºŠããã³ç±å®å®æ§ïŒè³é©æž©åºŠã50âä»
è¿ã§ãããPH7.0ã10åéåŠçã§ã¯55âãŸã§å®
å®ã§ããã (5) ååéïŒçŽ83000ïŒã²ã«éæ³ïŒ (6) çé»ç¹ïŒ3.92±0.05 (7) é»å®³å€ïŒCu2+ãã¢ã¹ã³ã«ãã³é žããžããªã¹
ã¬ã€ããŒã«ãã·ã¢ã³åã«ãªãŠã ã«ãã€ãŠé»å®³ã
ããã (8) å¯èŠéšåžåïŒ610nïœä»è¿ã«åžå極倧ããã€ã (9) ç³å«éïŒçŽ4.5ïŒ ã®ç³ãå«ãã (10) é å«éïŒïŒã¢ã«äžé ïŒã¢ã«å«ãã ïŒ ãšãã¿ã±å±ã«å±ããæ°èŠããªã«ãã³ã»ãªãã·
ããŒãŒçç£èãå¹é€ããå¹é€ç©ããäžèšã®çååŠ
çæ§è³ªãæããæ°èŠããªã«ãã³ã»ãªãã·ããŒãŒã
æ¡åããããšãç¹åŸŽãšããæ°èŠããªã«ãã³ã»ãªã
ã·ããŒãŒã®è£œé æ³ã (1) äœçšïŒé žçŽ ã®ååšäžãããªã«ãã³ãé žåãã
ããªãã«ãžã³ã淡玫è²ç©è³ªãçµãŠã»ãŒç¡è²ã®ç©
質ãçæããäœçšãæããããéé žåæ°ŽçŽ ãç
æããªãã (2) åºè³ªç¹ç°æ§ïŒããªã«ãã³ã«äœçšãããããªã
ã«ãžã³ã«ã¯è¥å¹²äœçšããããŸããããšããŒã«ã
ã«ãã³ãŒã«ããã€ããããã³ãªã©ã«ãäœçšã
ãã (3) è³é©PHããã³PHå®å®æ§ïŒè³é©PHã5.5ä»è¿ã§
ããã37âã60åéåŠçã§ã¯PHïŒãPHïŒã®éã§
å®å®ã§ããã (4) è³é©æž©åºŠããã³ç±å®å®æ§ïŒè³é©æž©åºŠã50âä»
è¿ã§ãããPH7.0ã10åéåŠçã§ã¯55âãŸã§å®
å®ã§ããã (5) ååéïŒçŽ83000ïŒã²ã«éæ³ïŒ (6) çé»ç¹ïŒ3.92±0.05 (7) é»å®³å€ïŒCu2+ãã¢ã¹ã³ã«ãã³é žããžããªã¹
ã¬ã€ããŒã«ãã·ã¢ã³åã«ãªãŠã ã«ãã€ãŠé»å®³ã
ããã (8) å¯èŠéšåžåïŒ610nïœä»è¿ã«åžå極倧ããã€ã (9) ç³å«éïŒçŽ4.5ïŒ ã®ç³ãå«ãã (10) é å«éïŒïŒã¢ã«äžé ïŒã¢ã«å«ãã ïŒ ãšãã¿ã±å±ã«å±ããæ°èŠããªã«ãã³ã»ãªãã·
ããŒãŒçç£èããšãã¿ã±ïŒ«â2593ïŒTrachyderma
tsunodae â2593ïŒã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®æ¹æ³ã[Claims] 1. A novel bilirubin with the following physical and chemical properties:
oxidase. (1) Action: Oxidizes bilirubin in the presence of oxygen,
Biliverdin has the effect of producing an almost colorless substance via a pale purple substance, but does not produce hydrogen peroxide. (2) Substrate specificity: acts on bilirubin, slightly acts on biliverdin, and also acts on phenol,
It also acts on catechol and hydroquinone. (3) Optimal PH and PH stability: The optimal PH is around 5.5, and when treated at 37°C for 60 minutes, it is stable between PH5 and PH9. (4) Optimal temperature and thermal stability: The optimal temperature is around 50°C, and it is stable up to 55°C when treated at PH7.0 for 10 minutes. (5) Molecular weight: Approximately 83,000 (gel filtration method) (6) Isoelectric point: 3.92±0.05 (7) Inhibitors: Inhibited by Cu 2+ , ascorbic acid, dithiothreitol, and potassium cyanide. (8) Visible absorption: Maximum absorption near 610 nm. (9) Sugar content: Contains approximately 4.5% sugar. (10) Copper content: Contains 4 moles of copper per mole. 2. A method for producing a novel bilirubin oxidase, which comprises culturing a novel bilirubin oxidase-producing bacterium belonging to the genus Ebitake, and collecting a novel bilirubin oxidase having the following physical and chemical properties from the culture. (1) Action: Oxidizes bilirubin in the presence of oxygen,
Biliverdin has the effect of producing an almost colorless substance via a pale purple substance, but does not produce hydrogen peroxide. (2) Substrate specificity: acts on bilirubin, slightly acts on biliverdin, and also acts on phenol,
It also acts on catechol and hydroquinone. (3) Optimal PH and PH stability: The optimal PH is around 5.5, and when treated at 37°C for 60 minutes, it is stable between PH5 and PH9. (4) Optimal temperature and thermal stability: The optimal temperature is around 50°C, and it is stable up to 55°C when treated at PH7.0 for 10 minutes. (5) Molecular weight: Approximately 83,000 (gel filtration method) (6) Isoelectric point: 3.92±0.05 (7) Inhibitors: Inhibited by Cu 2+ , ascorbic acid, dithiothreitol, and potassium cyanide. (8) Visible absorption: Maximum absorption near 610 nm. (9) Sugar content: Contains approximately 4.5% sugar. (10) Copper content: Contains 4 moles of copper per mole. 3. A novel bilirubin oxidase-producing bacterium belonging to the genus Ebitake is called Ebitake K-2593 (Trachyderma
tsunodae K-2593)
The method described in section.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58218895A JPS60110290A (en) | 1983-11-21 | 1983-11-21 | Novel bilirubin oxidase and its production |
US06/649,054 US4600689A (en) | 1983-11-21 | 1984-09-10 | Novel bilirubin oxidase, its production and use |
GB08422935A GB2146997B (en) | 1983-11-21 | 1984-09-11 | Novel bilirubin oxidase, its production and use |
CA000463878A CA1219792A (en) | 1983-11-21 | 1984-09-24 | Bilirubin oxidase, its production and use |
KR1019840005904A KR880000753B1 (en) | 1983-11-21 | 1984-09-26 | Novel bilirubin oxidase |
DE3436005A DE3436005C2 (en) | 1983-11-21 | 1984-10-01 | Novel bilirubin oxidase, process for its preparation and reagent preparation containing it |
FR8416064A FR2555196B1 (en) | 1983-11-21 | 1984-10-19 | NOVEL BILIRUBIN OXYDASE, PROCESS FOR PRODUCING THE SAME, REACTIVE COMPOSITION CONTAINING THE SAME AND ITS APPLICATION FOR DETERMINING BILIRUBIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58218895A JPS60110290A (en) | 1983-11-21 | 1983-11-21 | Novel bilirubin oxidase and its production |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60110290A JPS60110290A (en) | 1985-06-15 |
JPH0324198B2 true JPH0324198B2 (en) | 1991-04-02 |
Family
ID=16726988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58218895A Granted JPS60110290A (en) | 1983-11-21 | 1983-11-21 | Novel bilirubin oxidase and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60110290A (en) |
-
1983
- 1983-11-21 JP JP58218895A patent/JPS60110290A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60110290A (en) | 1985-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3157622B2 (en) | Fructosylamine deglycase, method for producing the same, and method for quantifying amadori compound using the enzyme | |
US4600689A (en) | Novel bilirubin oxidase, its production and use | |
Simpson et al. | Isolation, purification and characterization of a novel glucose oxidase from Penicillium sp. CBS 120262 optimally active at neutral pH | |
OHNISHI | Studies on Cytochrome b I. Isolation, Purification and Some Properties of Cytochrome b from Beef Heart Muscle | |
JPS604716B2 (en) | Novel choline oxidase and its production method | |
FUJII et al. | Purification and Properties of Dihydrogeodin Oxdase from Aspergillus terreus | |
US4985360A (en) | Novel bilirubin oxidase which has a substrate specifity to bilirubin, but not to biliverdin, catechol and hemin | |
US4677062A (en) | Process for producing bilirubin oxidase | |
US4698306A (en) | Process for producing peroxidase | |
FR2576909A1 (en) | THERMOSTABLE BILIRUBIN OXIDASE AND PROCESS FOR OBTAINING SAME | |
Ohe et al. | Purification and properties of xanthine dehydrogenase from Streptomyces cyanogenus | |
US4569912A (en) | Production of bilirubin oxidase | |
JPH0324198B2 (en) | ||
Takeuchi et al. | Pyruvate oxidase (CoA acetylating) in Entamoeba histolytica | |
US4610963A (en) | Novel glutathione oxidase, its production and use | |
US4927753A (en) | Quantitative determination of L-fucose | |
JP2647689B2 (en) | New acetylpolyamine amide hydrolase | |
JPS5828283A (en) | Improved method for producing choline oxidase | |
JPH03996B2 (en) | ||
JP2966513B2 (en) | Method for producing peroxidase | |
JP2000270855A (en) | Fructosylvaline oxidase | |
JP3040228B2 (en) | L-fucose dehydrogenase, method for producing the same, and method for quantifying L-fucose | |
JP3929576B2 (en) | Microorganism producing enzyme acting on phosphorylated 1,5-anhydroglucitol, enzyme produced by the microorganism, and method for quantifying phosphorylated 1,5-anhydroglucitol using the same | |
JPS62278981A (en) | Production of polyphenol oxidase | |
JPS6128386A (en) | Novel lactate oxidase, analytical method using it, and kit for analysis |